47 related articles for article (PubMed ID: 8975171)
1. [Our preliminary observations of plasma endothelin behavior in type II diabetes mellitus].
Bruno CM; Neri S; D'Amico R; Raciti C; Urso G
Minerva Med; 1996; 87(7-8):331-3. PubMed ID: 8975171
[TBL] [Abstract][Full Text] [Related]
2. Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.
Mangiafico RA; Malatino LS; Santonocito M; Spada RS
Int Angiol; 1998 Jun; 17(2):97-102. PubMed ID: 9754897
[TBL] [Abstract][Full Text] [Related]
3. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
4. Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus.
Perfetto F; Tarquini R; de Leonardis V; Piluso A; Becucci A; Anselmi B; Curradi C; Tapparini L; Tarquini B
Recenti Prog Med; 1997; 88(7-8):317-20. PubMed ID: 9270291
[TBL] [Abstract][Full Text] [Related]
5. The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia.
Lam HC; Chu CH; Wei MC; Keng HM; Lu CC; Sun CC; Lee JK; Chuang MJ; Wang MC; Tai MH
Exp Biol Med (Maywood); 2006 Jun; 231(6):1010-5. PubMed ID: 16741040
[TBL] [Abstract][Full Text] [Related]
6. [Significance of increased endothelin level for development of sequelae of diabetes mellitus].
Haak T; Jungmann E; Hillmann U; Felber A; Usadel KH
Med Klin (Munich); 1993 May; 88(5):291-6. PubMed ID: 8326915
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the diagnostic value of plasma endothelin for diabetic retinopathy using the receiver operating characteristic curve.
Zhu H; Shi CH
Ophthalmic Res; 2007; 39(5):289-93. PubMed ID: 17851270
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of serum endothelin in type 2 diabetic patients with vascular complications].
Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Chen YS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1007-8, 1011. PubMed ID: 16109562
[TBL] [Abstract][Full Text] [Related]
9. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
[TBL] [Abstract][Full Text] [Related]
10. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension.
Skalska AB; Pietrzycka A; Stepniewski M
Clin Biochem; 2009 Mar; 42(4-5):358-64. PubMed ID: 19046960
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus.
Zanatta CM; Gerchman F; Burttet L; Nabinger G; Jacques-Silva MC; Canani LH; Gross JL
Diabetes Res Clin Pract; 2008 May; 80(2):299-304. PubMed ID: 18346810
[TBL] [Abstract][Full Text] [Related]
12. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes.
Lim SC; Morgenthaler NG; Subramaniam T; Wu YS; Goh SK; Sum CF
Diabetes Care; 2007 Jun; 30(6):1513-9. PubMed ID: 17384335
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors.
Głowińska B; Urban M; Hryniewicz A; Peczyńska J; Florys B; Al-Hwish M
Kardiol Pol; 2004 Oct; 61(10):329-38. PubMed ID: 15841114
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
16. Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria.
Bruno CM; Valenti M; Bertino G; Ardiri A; Bruno F; Cunsolo M; Pulvirenti D; Neri S
Minerva Med; 2008 Feb; 99(1):1-5. PubMed ID: 18299691
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
18. Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages.
Mangiafico RA; Malatino LS; Santonocito M; Sarnataro F; Dell'Arte S; Messina R; Santangelo B
Panminerva Med; 1999 Mar; 41(1):22-6. PubMed ID: 10230252
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
20. Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type-2 diabetes: studies in gonadectomized and sham-operated Zucker diabetic rats.
Ajayi AA; Ogungbade GO; Okorodudu AO
Eur J Clin Invest; 2004 May; 34(5):349-57. PubMed ID: 15147332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
